CDKN1A and cancer: Since HIF-1α is involved in hypoxia-induced senescence by activating cyclin-dependent kinase inhibitors p21CIP1 and p27KIP1 or inhibiting M-phase inducer CDC25A, anti-HIF-1α strategies may increase the action of anti-cancer agents by abating the senescent phenotype.